World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
25298
World Ranking
18675
National Ranking
689

Overview

Marjolein Drent is affiliated with Maastricht University in the Netherlands and has conducted extensive research primarily in the field of Medicine, with a strong focus on Pulmonary and Respiratory Medicine. Their scholarly output reflects a significant engagement with respiratory diseases, especially sarcoidosis and interstitial lung diseases.

The scientist's research spans several subfields including Physiology, Epidemiology, Public Health, Environmental and Occupational Health, and Endocrinology, Diabetes and Metabolism. Within these areas, the main topics of work include:

  • Sarcoidosis and Beryllium Toxicity Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Drug-Induced Adverse Reactions
  • Vasculitis and related conditions
  • Pituitary Gland Disorders and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Chronic Obstructive Pulmonary Disease (COPD) Research

Marjolein Drent has contributed to a variety of academic venues, with frequent publications appearing in:

  • Current Opinion in Pulmonary Medicine
  • The Lancet Respiratory Medicine
  • PubMed
  • Ocular Immunology and Inflammation
  • Endocrine Abstracts

Among the recent papers authored or coauthored by Drent are:

  • "Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline" (2020), published in American Journal of Respiratory and Critical Care Medicine
  • "ERS clinical practice guidelines on treatment of sarcoidosis" (2021), published in European Respiratory Journal
  • "Challenges of Sarcoidosis and Its Management" (2021), published in New England Journal of Medicine
  • "Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis" (2020), published in European Respiratory Review
  • "Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes" (2021), published in Diagnostics

Frequent collaborators in Drent's work include:

  • Aalt Bast
  • Petal A. Wijnen
  • Elyse E. Lower
  • Naomi T. Jessurun
  • Otto Bekers

Best Publications

  • An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King

  • An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

    Keith C. Meyer;Ganesh Raghu;Robert P. Baughman;Kevin K. Brown

  • Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

    Robert P. Baughman;Marjolein Drent;Mani Kavuru;Marc A. Judson

  • Diagnosis and Detection of Sarcoidosis An Official American Thoracic Society Clinical Practice Guideline

    Elliott D. Crouser;Lisa A. Maier;Kevin C. Wilson;Catherine A. Bonham

  • Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation

    M. Drent;N. A. M. Cobben;R. F. Henderson;E. F. M. Wouters

  • Association of man-made mineral fibre exposure and sarcoidlike granulomas.

    M. Drent;P.H.H. Bomans;R.J. Van Suylen;R.J.S. Lamers

  • Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS).

    Jolanda de Vries;Helen Michielsen;Guus L. Van Heck;Marjolein Drent

  • The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool

    Marc A. Judson;Ulrich Costabel;Marjolein Drent;Athol Wells

  • Neurosarcoidosis: a clinical dilemma.

    Elske Hoitsma;Carin G Faber;Marjolein Drent;Om P Sharma

  • ERS clinical practice guidelines on treatment of sarcoidosis

    Robert P. Baughman;Dominique Valeyre;Peter Korsten;Alexander G. Mathioudakis

  • Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group

    Barney J. Stern;Walter Royal;Jeffrey M. Gelfand;David B. Clifford

  • Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial

    M.A. Judson;R.P. Baughman;U. Costabel;S. Flavin

  • Sarcoidosis in America. Analysis Based on Health Care Use.

    Robert P. Baughman;Shelli Field;Ulrich Costabel;Ronald G. Crystal

  • Sarcoidosis associated fatigue

    Marjolein Drent;Elyse E. Lower;Jolanda De Vries

  • Small fiber neuropathy: a common and important clinical disorder.

    E. Hoitsma;J.P.H. Reulen;M. de Baets;M. Drent

  • Small fibre neuropathy in sarcoidosis

    E Hoitsma;M Marziniak;C G Faber;J P H Reulen

  • Challenges of Sarcoidosis and Its Management

    Marjolein Drent;Elliott D Crouser;Johan Grunewald

  • Quality of life of idiopathic pulmonary fibrosis patients

    J. De Vries;B.L.J. Kessels;M. Drent

  • Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis

    Agnes W. Boots;Marjolein Drent;Vincent C.J. de Boer;Vincent C.J. de Boer;Aalt Bast

  • Efficacy of infliximab in extrapulmonary sarcoidosis : results from a randomised trial. Editorial

    M. A. Judson;R. P. Baughman;U. Costabe;S. Flavin

Frequent Co-Authors

Robert P. Baughman
Robert P. Baughman University of Cincinnati
Aalt Bast
Aalt Bast Maastricht University
Emiel F.M. Wouters
Emiel F.M. Wouters Maastricht University
Jan Jacobs
Jan Jacobs KU Leuven
Ulrich Costabel
Ulrich Costabel University of Duisburg-Essen
Marc A. Judson
Marc A. Judson Albany Medical Center Hospital
Paul G.H. Mulder
Paul G.H. Mulder Erasmus University Rotterdam
Piet Geusens
Piet Geusens Maastricht University
Cathrien A. Bruggeman
Cathrien A. Bruggeman Maastricht University Medical Centre
Guido R.M.M. Haenen
Guido R.M.M. Haenen Maastricht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in healthcare or medicine opens many doors beyond the traditional MD route. Many students are now seeking flexibility and affordability through online study options that lead to high-demand roles. For registered nurses wanting to advance their qualifications, cheapest accredited online rn to bsn programs are a cost-effective way to pursue career growth without significant financial strain.

Non-nursing graduates interested in nursing careers can consider accelerated options like an online direct entry msn program. These intensive courses allow students to transition into nursing leadership roles quickly.

For those concerned about admission requirements, learning what is the easiest nursing program to get into can help identify accessible schools and increase your chances of acceptance.

If you're interested in the administrative side of healthcare, there are medical billing and coding schools that accept financial aid, making this field more accessible than ever. Each pathway can lead to rewarding roles in the healthcare industry, offering a range of opportunities for different backgrounds and schedules.

Best Scientists Citing Marjolein Drent

Trending Scientists